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Abstract:  
Background: Overestimations of non-prescribed stimulant use of peers are well documented in the 
U.S.A. and have also been identified as predictive of personal stimulant consumption. This study 
aimed to examine whether overestimations of peer use and approval of the use are associated with 
personal use and attitude towards the use of non-prescribed stimulants among European university 
students. 
Method: The EU funded ‘Social Norms Intervention for the prevention of Polydrug usE (SNIPE)’ study 
was conducted in seven European countries. In a web-based questionnaire, 4,482 students were 
asked about their personal use and their attitude towards non-prescribed stimulant use, as well as 
the perceived peer use and peer attitude. 
Results: 59% of students thought that the majority of their peers used non-prescribed stimulants 
more frequently than themselves, and only 4% thought that the use of the majority was lower than 
their personal use. The perception that the majority of peers had used non-prescribed stimulants at 
least once was significantly associated with higher odds for personal use of non-prescribed 
stimulants (OR: 3.30, 95% CI: 2.32-4.71). In addition, the perception that the majority of peers 
approved of the non-prescribed use of stimulants was associated with a 4.03 (95% CI: 3.35-4.84) 
times higher likelihood for personal approval. 
Discussion: European university students generally perceived the non-prescribed use of stimulants of 
peers to be higher than their personal use. This perception, as well as a perception of higher approval 
in the peer group, was associated with a higher likelihood of personal non-prescribed stimulant 
medication use and approval. 
 
Keywords: prescription stimulant, nonmedical use, non-prescribed, university students, 
misperceptions, social norms 
3 
 
1. Introduction: 
The nonmedical use of prescription medicines (NMUPM) is a debated topic in science, society and 
media (Arria and DuPont, 2010). For instance, interest in this topic was stirred in 2008 when one 
informal online poll revealed that 20% of a sample of 1,400 scientists from 60 countries reported that 
they had used medicines not prescribed by a physician to stimulate their focus, concentration, or 
memory (Maher, 2008). Currently, there are several prescription medicines available that are known 
for their potential to enhance cognitive functioning. One well-known substance is the stimulant 
‘methylphenidate’ which is used for attention deficit hyperactivity disorder (ADHD) treatment. 
Methylphenidate formulations like Ritalin® and Concerta® are approved in Europe for the treatment 
of ADHD in children and adolescents, as well as for persons continuing treatment into adulthood. 
Regarding the approval of ADHD treatment for persons diagnosed in adulthood, there are differences 
across European countries. In Germany, methylphenidate is approved for treatment of adult ADHD 
(BfArM, 2011) and in the U.K., adult ADHD is recognized as a condition (Drummond, Arkley, 2009) 
whereas other countries, such as Belgium and Denmark, only approved methylphenidate for 
treatment of ADHD in children and adolescents aged 6–17 years. Methylphenidate was also the 
substance most commonly used by those scientists that reported cognitive enhancement in the 
above-mentioned study (Maher, 2008).  
Previous research has demonstrated that the prevalence of NMUPM can be particularly high among 
university and college student populations compared to their same-age counterparts in the general 
population (Herman-Stahl et al., 2007). Most lifetime nonmedical users of prescription stimulants 
started consuming during high school (Austic, 2015) or during their early college years (Teter et al., 
2006). Within the range of prescription medicines, stimulants  were more often used by students 
compared to other medications, such as pain relief or anti-anxiety medications (Brandt et al., 2014). 
Reasons for nonmedical use of prescription stimulants (NMUPS) among university students are to 
improve concentration and to perform better in university (Teter et al., 2006). Considering the 
existing evidence base of NMUPS, in our study, NMUPS was defined as the nonmedical use of 
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medication which was not prescribed and which was used with the intention to improve academic 
performance. 
The nonmedical use of prescription stimulants to improve cognitive achievement has raised some 
public health concerns because of possible adverse side effects in healthy young adults (Lakhan and 
Kirchgessner, 2012). Furthermore, an approved medication intended for a different indication may 
give consumers a false impression of such medication’s safety combined with a low awareness of 
possible side effects if used non-prescribed (Compton and Volkow, 2006). Indeed, research has 
shown that NMUPS is associated with a higher likelihood to use other substances, including alcohol, 
tobacco and cocaine (Sepulveda et al., 2011). This is a major concern, because previous research 
suggested that students who used non-prescribed stimulants and alcohol simultaneously 
experienced considerably more negative consequences of use compared to students that did not use 
both substances at a time (Egan et al., 2013). 
One highly influential factor in predicting substance use behavior in young people is the perception 
of the behavior among peers. Research in this field showed that inaccurate perceptions regarding 
others’ substance use behavior exist (Perkins, 1997; Perkins, 2007). Young adults may falsely assume 
that the peer group behaves differently from the actual existing norm (misperception) or from their 
individual self-reported behavior (self-other discrepancies) (Borsari and Carey, 2003). Perceptions of 
substance use in the peer group can be related to the quantity and frequency of peer substance use 
(descriptive norm) or to perceptions of peer approval of substance use (injunctive norm). Most 
evidence on incorrect perceptions regarding substance use in student populations is related to 
descriptive norms regarding alcohol use (Berkowitz, 2004; Page et al., 2008; Perkins et al., 2005; 
Perkins et al., 1999). It is known that perceived descriptive norms of peer alcohol use have an impact 
on individual drinking behavior. Studies showed that the perception of alcohol use among peers is 
related with higher likelihood of personally consuming alcohol more heavily (Lintonen and Konu, 
2004; Perkins, 2007; Perkins and Wechsler, 1996). However, the role of descriptive norms in relation 
to NMUPS is not well understood. Furthermore, only a few studies have investigated the role of 
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perceived injunctive norms in predicting personal substance use behavior. There is some indication 
that perceived peer approval of alcohol (McAlaney et al., 2015), tobacco (Pischke et al., 2015) and 
illicit substance use (Dempsey et al., 2016, Helmer et al., 2014) is associated with the personal 
approval toward such substances. Neighbors and colleagues also suggested that an association 
between injunctive drinking norms of proximal reference groups and personal drinking exists 
(Neighbors et al., 2008). However, we are unaware of any studies focussing on associations between 
perceived NMUPS approval and personal NMUPS in student populations.  
The objectives of this study were to describe NMUPS among students from seven European 
countries, to assess discrepancies between estimated peer and personal NMUPS behavior/approval 
and to determine whether perceptions of peer norms are associated with personal NMUPS 
behavior/approval.  
2. Methods: 
2.1. Data: 
The ‘Social Norms Intervention for the prevention of Polydrug usE’ (SNIPE)- project was a cross- 
national study which included students from universities in Belgium, Denmark, Germany, the Slovak 
Republic, Spain, Turkey and the United Kingdom. The project was funded by the European 
Commission (LS/2009-2010/DPIP/AG). The overall objective of SNIPE was to test the feasibility of a 
web-based personalised ‘social norms’-feedback intervention for substance use for European 
students of the respective universities (for further detail, see Pischke et al., 2012). In brief, students 
were recruited from at least one designated intervention and one delayed intervention control 
university (McAlaney et al., 2015). In each country different means were used to recruit participants 
to register on the survey website, including emails, class announcements, and printed flyers. 
Subsequently, a hyperlink to the survey webpage was emailed to the registered participants. Study 
participation was voluntary and participants were informed that their information was 
pseudonymised at study entry by replacing email-addresses with artificial identifiers in datasets. 
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Students at the intervention universities received access to the ‘social norms’ feedback immediately 
after baseline assessment of licit and illicit substance use, those enrolled at the delayed intervention 
control universities received access to the online-feedback after the follow-up was completed at the 
intervention universities 5 months later. In the current manuscript, baseline results are reported for 
both, students at intervention and delayed-intervention control universities. Statistical analysis was 
conducted based on an anonymous dataset. In each country, the participating universities obtained 
ethical approval from the respective responsible authorities. 
The survey included questions on the student’s personal use of licit (alcohol, tobacco), illicit 
substances (i.e. cocaine, ecstasy, amphetamines), as well as the personal NMUPS to improve 
academic performance. Students were also asked about their personal attitudes towards the use of 
these substances. Furthermore, perceptions of peer substance use behaviors and attitudes among 
students were assessed. Demographic data were also collected, including respondents age, gender, 
migrant status, year of study and living situation (with other students or not).  
 
2.2. Measurements: 
To measure personal NMUPS, students were asked how often they used a medication which was not 
prescribed to improve academic performance followed by an example of a registered local trade 
name (Ritalin®) in six countries and the active component (Methylphenidate) in Turkey. Concerning 
their perceptions of NMUPS peer use, respondents were asked a question that was tailored to their 
gender and university: “How often in the last two months do you think most (at least 51%) of the 
[female/male] students at your university have used the following?”. Response options for both 
questions ranged from ‘Never in my/their life’, ‘Have used but not in the last two months’ to ‘Every 
day or nearly every day’. 
Moreover, information about students’ personal attitude towards NMUPS was collected employing 
the question “Which of the following best describes your attitude to using each of these 
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substances?”. Furthermore, students were asked about their perceptions of attitudes towards using 
NMUPS among their peers, using a sex-specific question “Which of the following do you think best 
describes the attitude of most (at least 51%) of the female/male students at your university to the 
use of each of these substances?”. Response options for both questions were ‘Never ok to use’, ‘Ok 
to use occasionally if it doesn’t interfere with study or work’, ‘Ok to use frequently if it doesn’t 
interfere with study or work’, ‘Ok to use occasionally even if it does interfere with study or work’, ‘Ok 
to use frequently if that is what the person wants to do’. Country, sex, age, year of study and living 
situation were considered potential determinants of NMUPS use/attitude towards NMUPS. 
 
2.3. Statistical analysis: 
Firstly, we estimated the personal substance use and attitudes towards NMUPS and 95% bootstrap 
confidence intervals based on 1,000 bootstrap samples for each participating country. From the 
study population, bootstrap samples were repeatedly drawn with replacement and personal 
substance use prevalence was calculated. Empirical distribution of the bootstrap estimate was used 
to derive 2.5- and 97.5-percentiles as confidence limits. Secondly, participants´ self-other 
discrepancies were classified into three groups considering whether they personally perceived the 
NMUPS of the majority of same-sex peers as higher/ identical/ lower as the report of the 
corresponding personal behavior estimate. Thirdly, two binary logistic regression analyses were 
conducted to examine associations between perceived and personal behaviors (model 1) and 
perceived and personal attitudes (model 2). Sex, age, year of study, living situation and perceived 
substance use were included as independent variables in model 1. In model 2, all demographic 
variables, perceived attitude and personal NMUPS use were added as independent variables. In both 
models age was included as a continuous variable and all others as categorical variables. We added 
personal NMUPS use to the second model to assess whether the effect of perceived approval of 
NMUPS on personal approval of NMUPS is mediated by personal use. Furthermore, we examined 
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whether sex or country moderated the association between perception and personal 
behavior/attitude by adding interaction terms to both models. If interaction terms were significant at 
the p < 0.05 level, we conducted stratified analyses. Data analysis was done with SPSS for windows, 
version 22.0. 
 
3. Results: 
The study included a total of 4,482 university students (71% female). Participant numbers across 
countries varied from 1,938 students in the Slovak Republic (43%) and 858 in Turkey (19%) to 504 in 
Germany (11%), 464 in Denmark (10%), 426 in Belgium (10%), 185 in Spain (4%) and 107 in the UK 
(2%). A detailed description of the sample is provided elsewhere (Helmer et al., 2014). Data on non-
prescribed stimulant use/attitudes towards the use were available for 4,433/4,337 students.  
Across all countries, 6% of the participants reported having used non-prescribed stimulants at least 
once in their life. Lifetime NMUPS was least common in Denmark (2%) and most common in the UK 
(11%). The majority of the overall sample stated that “it is never okay to use” non-prescribed 
stimulants (Table 1). In all countries, except for Turkey and Denmark, more than half of the students 
perceived that the majority of their same-sex peers had used non-prescribed stimulants at least once 
in their life. In the overall sample across countries, 50% thought that the majority of their peers used 
non-prescribed stimulants more frequently than themselves, 44% thought that the use was identical 
and only 6% thought that the use of the majority of their peers was lower than their personal use. 
91% of students perceived that the peer approval towards NMUPS was identical or higher than their 
personal approval (Table 2).  
Binary logistic regression model 1 revealed that the perception that the majority of same-sex peers 
had used non-prescribed stimulants at least once in their life was significantly associated with higher 
odds for personal use (OR: 3.30, 95% CI: 2.32-4.71). Examining injunctive norms, model 2 showed 
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that students´ perceptions that the majority of same-sex peers approved NMUPS was associated 
with a 4.03 (95% CI: 3.35-4.84) higher likelihood of personal approval of NMUPS use (Table 3). 
In model 1, interaction terms showed that the effect of perception on NMUPS was not modified by 
country or by sex. Interaction analysis in model 2 revealed a significant modification by country on 
perceived attitude but no significant interaction by gender was observed. A stratified analysis of 
attitude towards NMUPS by country showed that the association between perceived peer attitudes 
and personal attitudes towards NMUPS use remained significant in all countries except for the UK.  
 
4. Discussion:  
The present study investigated the personal and perceived use of non-prescribed stimulants to 
improve academic performance and the personal and perceived attitudes towards using those 
medications in university students from seven European countries. Study participants generally 
perceived the NMUPS of the majority of their peers to be higher than their personal use. In addition, 
the majority of students perceived their peers to be equally or more approving of NMUPS than 
themselves. The descriptive norms were associated with an elevated personal NMUPS, the injunctive 
norms were associated with an elevated personal approval of NMUPS. To our knowledge, no other 
study has presented data on perceptions and use of non-prescribed stimulants in a large sample of 
university and college students enrolled at various universities across Europe. 
Our study demonstrated that the use of non-prescribed stimulants differed between surveyed 
countries. This is in line with previous research (Schelle et al., 2015). In fact, the literature not only 
shows clear differences in the use of non-prescribed stimulants between countries but also within 
countries (McCabe et al., 2005). In a U.S.-study (McCabe et al., 2005), the 12-months prevalence of 
NMUPS ranged between 0 and 25% of students in participating colleges. More recent studies 
examining NMUPS among undergraduates demonstrated 12-month prevalences between 6% 
(McCabe, 2008) and 10% (Egan et al., 2013). A further study examining the lifetime prevalence of 
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NMUPS indicated that even 34% of the respondents said they had used NMUPS (DeSantis et al., 
2008). To date, only a limited number of studies have examined NMUPS in European students. These 
studies reported considerable differences in NMUPS prevalence. For instance, a study among 512 
German university students reported a lifetime prevalence of 1% (Franke et al., 2011) and a more 
recent study including 3,798 Flemish university students showed a 5% lifetime NMUPS prevalence 
(Ponnet et al., 2015). Interestingly, in another study by Dietz et al. (2013) the 12-month prevalence of 
using cognitive-enhancing stimulants among 2,569 German university students was 20% which was 
considerably higher than the lifetime estimate found in other studies.  
Various reasons for these differences in reported prevalence are conceivable. First of all, the 
frequency of use may vary internationally or between college or university campuses (DeSantis et al., 
2008). Also, NMUPS may be increasing by duration or stage of study, therefore variation can be 
expected between our study and other studies focused on undergraduate students (McCabe, 2008) 
or studies that made additional efforts to survey students in the years post-graduation (DeSantis et 
al., 2008). Furthermore, in our study, students were only asked to report the perception of peer 
use/personal use of medication which was not prescribed to improve academic performance. In the 
majority of the other studies reporting on NMUPS, broader definitions of NMUPS were used which 
may account for differences in the reported NMUPS. Also, some of these studies included other 
stimulants that are available without a prescription, such as caffeine (Dietz et al., 2013). 
Furthermore, timeframes of assessment in other epidemiological studies typically refer to use in the 
last year. In our study, we chose a 2-months timeframe because it covered the period during which 
students were attending university excluding semester breaks. Moreover, similar to McCabe et al. 
(2008; 2005), we used web-based surveys whereas other studies used paper and pencil 
questionnaires to survey NMUPS (DeSantis et al., 2008; Dietz et al., 2013) which may result in a 
different response rate..  
The majority of surveyed participants in this study displayed self-other discrepancies in NMUPS 
meaning that they were under the assumption that the majority of their peers had used non-
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prescribed medication more often than themselves. To date, no other study has evaluated self-other 
discrepancies. However, one U.S.-study compared perceptions of NMUPS and the actual median 
value of self-reported use demonstrating overestimations (Sanders et al., 2014). Another study by 
McCabe et al. (2008) showed misperceptions by contrasting perception of NMUPS and the actual use 
at the university. In the mentioned study students thought that on average 20% of their peers on 
campus had used NMUPS at least once in the past year in contrast to an actual rate of 6.0% of peers 
reporting NMUPS in the last 12 months. In this sample, 70.2% of students overestimated the 
prevalence of NMUPS of their peers (McCabe, 2008). More recently Kilmer et al. (2015) found that 
89% of the students perceived that a typical student at their university had used stimulants either 
with or without a prescription at least once, yet the data on NMUPS suggested that the majority of 
students had been abstinent. DeSantis et al. (2013) took a closer look at the perceived NMUPS 
among distributors of those substances, i.e., fellow students with a medical prescription for ADHD 
stimulants distributing those to students without prescriptions and showed that overestimations also 
existed in this subgroup.  
Our study is the first examining the discrepancy between the personal and perceived peer approval 
of NMUPS. We found that 39% of the participating students thought that their peers were more 
approving of NMUPS than themselves. To our knowledge there is only one study by Maher (2008) 
based upon an informal online poll that examined NMUPS approval among scientists. This study 
showed that the approval of NMUPS was relatively high with four-fifths of the respondents reporting 
that healthy adults should be able to use medication not prescribed for them if they want to (Maher, 
2008). However, in terms of alcohol use among students, there is extensive meta-analytic evidence 
that a gap exists between students’ personal attitudes towards alcohol use and the perceived 
approval of other students (Borsari and Carey, 2003). Students viewed their peers to be more 
approving of alcohol use than they actually were (Borsari and Carey, 2003). Research examining this 
gap for a range of illicit substances (e.g. Cocaine, Amphetamines) revealed comparable results 
(Helmer et al., 2014).  
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University students across all participating countries who thought that the majority of peers used 
non-prescribed medication were more likely to report personal NMUPS. This association is consistent 
with findings of Kilmer et al. (2015) among U.S.-students. Findings of other studies (e.g. McCabe, 
2008; Sanders et al., 2014) suggest that users of non-prescribed medication were more likely to 
overestimate use of the corresponding substance in their peer group. Our study also revealed an 
association between perceived peer approval and personal approval of NMUPS. Similar findings have 
been reported in the SNIPE study with respect to other licit (McAlaney et al., 2015; Pischke et al., 
2015) and illicit substances (Helmer et al., 2014). 
However, this study had certain limitations. The use of self-report data may have resulted in 
underestimates or overestimates of NMUPS prevalence, depending on respondents’ own 
recollection and willingness to report illicit stimulant use. It is noteworthy that data were collected 
via a confidential online survey, which has been shown to produce high quality data in substance use 
research in university students (Kypri et al., 2004). The measure for NMUPS employed in this study 
may have also led to underreporting because only a choice of local trade names (e.g. Ritalin®) or the 
active component was included as an example. Furthermore, differences in medical availability of 
methylphenidate and other prescribed stimulants in Europe may have contributed to differences in 
NMUPS by country; however, because the main focus of our study was not on potential between-
country differences, differences are not reported in this article. Another factor that may have caused 
a certain degree of misreporting of NMUPS could have been that we asked participants for their 
individual e-mail addresses in order to be able to subsequently send them the link to the intervention 
after the completion of the baseline survey. This may have caused concerns regarding anonymity 
among study participants; however, participants were informed that their e-mail addresses were not 
included in the analysis datasets, and would be deleted as soon as possible. In addition, our sample is 
not representative for student populations in the different countries as we conducted the survey at 
single universities in the respective countries, using broad, but voluntary recruitment without being 
able to systematically address all students. At the majority of universities, e-mail was used to invite 
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students to participate in the study. Specifically, distribution lists provided by university 
administrations were used to reach students. However, because no data are available regarding the 
use of university email by students at the respective universities, we can only provide rough 
estimates of the number of students reached at each university. We therefore chose not to include 
this information in the current article. Therefore, we cannot rule out that selection bias may have led 
to higher or lower rates of self-reported use of non-prescribed stimulants in students. Lastly, the 
cross-sectional analysis of baseline data does not allow for causal inferences regarding the 
association between perceptions and personal use.  
There are several potential consequences associated with the non-prescribed prescription stimulant 
use, such as not receiving a medical instruction, unknown health consequences and involvement in 
other substance use (McCabe et al., 2006). Hence, suitable prevention strategies are required. Our 
data suggest that interventions focused on the prevention of NMUPS should take the important role 
of descriptive and injunctive norms among European college populations into account. However, to 
further tailor interventions to this target group, more information is needed on why certain students 
show self-other discrepancies while others do not. Also, findings by Austic (2015) indicate that the 
peak of incidence rates for nonmedical use of prescription stimulants occurred between the ages of 
16 and 19 years (Austic, 2015), suggesting that interventions should target misperceptions at an 
earlier age and should possibly be implemented in the school setting. Furthermore, the motives 
behind the use should be taken into account when designing future prevention strategies. Studies in 
this area of research suggest that the main motives for NMUPS are expectations of improved 
concentration and vigilance. Furthermore, high stress levels and academic workload were found to 
be associated with these motives (Eickenhorst et al., 2012), suggesting that students tend to use 
stimulants when they are overwhelmed with academic demands.  
To conclude, the findings of this cross-national study extend the body of international literature 
regarding students’ use of non-prescribed medication to improve academic performance. Further 
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quantitative and qualitative research is needed to better understand NMUPS and factors involved in 
NMUPS from the perspective of students. 
Final trial registration number: 
DRKS00004375 on the ‘German Clinical Trials Register’. 
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Table 1: Personal NMUPS and approval of NMUPS by country and sex (95% bootstrap CI) 
 
 
* ‘Ok to use occasionally if it doesn’t interfere with study or work’, ‘Ok to use frequently if it doesn’t interfere with study or work’ were collapsed into Ok to use if it doesn’t 
interfere with work or study  
**‘Ok to use occasionally even if it does interfere with study or work’, ‘Ok to use frequently if that is what the person wants to do’ were collapsed into Ok to use 
 
 
 
 
  Belgium Denmark Germany Slovak Republic Spain Turkey UK 
  Male Female Male Female Male Female Male Female Male Female Male Female Male Female 
NMUPS 
(%) 
(n=4433) 
 
Used in the 
last two 
months 
2.4 
(0.0-
6.1) 
2.5 (0.9-
4.4) 
0.0 
(0.0-
0.0) 
0.0 
(0.0-
0.0) 
2.5 
(0.5-
4.8) 
0.3 
(0.0-
1.1) 
1.6 
(0.5-
2.9) 
3.5 
(2.6-
4.6) 
0.0 
(0.0-
0.0) 
0.8 
(0.0-
2.5) 
1.1 
(0.3-
2.2) 
0.7 
(0.0-
1.6) 
3.1 
(0.0-
11.1) 
1.4 
(0.0-
4.6) 
Used once in 
their life 
7.1 
(2.2-
13.3) 
4.4 (2.3-
6.8) 
4.1 
(0.9-
8.3) 
1.7 
(0.6-
3.3) 
6.9 
(3.6-
10.8) 
1.7 
(0.3-
3.4) 
8.4 
(5.7-
11.4) 
8.3 
(6.9-
9.7) 
4.0 
(0.0-
10.4) 
5.6 
(1.7-
10.2) 
2.7 
(1.1-
4.5) 
4.8 
(2.7-
6.9) 
12.5 
(2.9-
24.3) 
10.0 
(4.0-
17.6) 
Approval 
of 
NMUPS 
(%) 
(n=4337) 
Never ok to 
use 
 
 
Ok to use if it 
doesn’t 
interfere with 
work or 
study* 
 
Ok to use** 
72.9 
(63.2-
82.3) 
 
21.2 
(12.1-
30.0) 
 
 
 
5.9 
(1.2-
11.4) 
72.0 
(67.0-
76.8) 
 
25.8 
(20.9-
30.8) 
 
 
 
2.2 (0.6-
4.0) 
80.4 
(72.3-
88.3) 
 
11.3 
(5.1-
18.5) 
 
 
 
8.2 
(3.2-
14.3) 
89.5 
(86.2-
92.7) 
 
7.3 
(4.5-
10.1) 
 
 
 
3.2 
(1.4-
5.2) 
70.4 
(63.8-
76.9) 
 
22.7 
(17.1-
28.8) 
 
 
 
6.9 
(3.5-
10.7) 
78.8 
(74.1-
83.7) 
 
16.4 
(12.0-
20.7) 
 
 
 
4.8 
(2.4-
7.3) 
74.4 
(69.9-
78.8) 
 
22.5 
(18.4-
26.5) 
 
 
 
3.1 
(1.5-
4.9) 
67.9 
(65.5-
70.4) 
 
30.0 
(27.6-
32.3) 
 
 
 
2.1 
(1.4-
2.9) 
74.0 
(61.4-
85.7) 
 
22.0 
(10.8-
33.3) 
 
 
 
4.0 
(0.0-
10.0) 
64.0 
(55.1-
72.1) 
 
30.4 
(22.4-
38.7) 
 
 
 
5.6 
(2.2-
9.7) 
88.2 
(84.6-
91.4) 
 
9.6 
(6.7-
12.8) 
 
 
 
2.1 
(0.8-
3.7) 
88.3 
(85.2-
91.2) 
 
10.0 
(7.2-
12.8) 
 
 
 
1.7 
(0.5-
3.0) 
53.1 
(34.9-
71.0) 
 
40.6 
(22.6-
59.0) 
 
 
 
6.3 
(0.0-
15.2) 
75.7 
(65.2-
85.1) 
 
18.6 
(10.3-
28.4) 
 
 
 
5.7 
(0.0-
11.8) 
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Table 2: Differences between personal NMUPS /approval of NMUPS and the perceived NMUPS /approval of NMUPS of the majority of peers of the same sex 
and same university (self-other discrepancies) 
 Lifetime 
NMUPS 
(%) (n=4433) 
Approval of 
NMUPS (%) 
(n=4337) 
Majority of 
their same-
sex peers < 
own 
3.8 8.8 
Majority of 
their same-
sex peers = 
own 
37.3 52.5 
Majority of 
their same-
sex peers > 
own 
58.9 38.7 
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Table 3: Associations between personal NMUPS /personal attitude towards NMUPS and perceived 
lifetime NMUPS of peers/ attitude of peers, personal NMUPS, country, age, sex as well as living 
situation– Results of binary log. Regressions 
Variables Ever used NMUPS Positive attitude towards 
NMUPS (okay to use and 
okay to use if it does not 
interfere with study or work) 
  OR (95% CI) OR (95% CI) 
Perceived peer behavior (Lifetime NMUPS) 3.30 (2.32-4.71)  
Perceived peer behavior  (Not used NMPS) 1.00  
Perceived peer attitude towards NMUPS 
(Never okay to use) 
-- 1.00 
Perceived peer attitude towards NMUPS use 
(okay to use) 
-- 4.03 (3.35-4.84) 
Never used NMUPS  1.00 
Ever used NMUPS  13.65 (9.73-19.15) 
Country    
Slovak Republic 1.00 1.00 
Belgium 0.52 (0.33-0.85) 0.80 (0.61-1.04) 
Denmark 0.29 (0.14-0.60) 0.62 (0.43-0.89) 
Germany 0.42 (0.25-0.72) 1.07 (0.82-1.40) 
Spain 0.55 (0.27-1.11) 1.14 (0.84-2.90) 
Turkey 0.58 (0.39-0.88) 1.27 (0.86-1.80) 
United Kingdom 1.35 (0.69-2.66) 0.44 (0.32-0.58) 
Age 0.99 (0.96-1.04) 0.96 (0.93-0.98) 
Sex    
Female 1.00 1.00 
Male  1.24 (0.93-1.65) 1.04 (0.87-1.26) 
Living situation     
With other students 1.00 1.00 
Alone or with partner 0.94 (0.62-1.40) 0.92 (0.71-1.18) 
18 
 
With parents 0.79 (0.59-1.06) 0.97 (0.81-1.17) 
Other 0.72 (0.32-1.62) 0.77 (0.47-1.26) 
†All variables in the table were included in the logistic regression analysis and are therefore controlled for. Year 
of study was included as a categorical variable in the model but was not found to be a significant predictor and 
is not shown in the table. 
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